InsiderTrades.com logo

CATX Insider Trading

Insider Ownership Percentage: 3.72%
Insider Buying (Last 12 Months): $298,619.43
Insider Selling (Last 12 Months): $0.00

Perspective Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Perspective Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Perspective Therapeutics Share Price & Price History

Current Price: $4.45
Price Change: ▼ Price Decrease of -0.15 (-3.26%)
As of 03/20/2026 05:10 PM ET

This chart shows the closing price history over time for CATX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Perspective Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/13/2025Jonathan Robert HuntCAOBuy11,000$2.03$22,330.0059,800View SEC Filing Icon  
11/12/2025Robert F. Williamson, IIIDirectorBuy9,498$2.10$19,945.809,864View SEC Filing Icon  
3/31/2025Robert F. Williamson, IIIDirectorBuy38,145$2.14$81,630.30108,982View SEC Filing Icon  
3/28/2025Johan M SpoorCEOBuy22,026$2.24$49,338.2459,383View SEC Filing Icon  
3/28/2025Juan GrahamCFOBuy33,333$2.25$74,999.2535,354View SEC Filing Icon  
3/28/2025Robert F. Williamson, IIIDirectorBuy22,192$2.27$50,375.8470,837View SEC Filing Icon  
12/4/2024Heidi HensonDirectorBuy25,975$3.85$100,003.7525,975View SEC Filing Icon  
12/4/2024Johan M SpoorCEOBuy8,000$3.77$30,160.0036,257View SEC Filing Icon  
11/25/2024Johan M SpoorCEOBuy14,500$3.78$54,810.00152,072View SEC Filing Icon  
11/25/2024Jonathan Robert HuntCFOBuy12,829$3.82$49,006.7848,800View SEC Filing Icon  
11/25/2024Robert F. Williamson, IIIDirectorBuy6,266$3.64$22,808.24430,058View SEC Filing Icon  
6/17/2024Jonathan Robert HuntCFOBuy1,800$9.81$17,658.0035,971View SEC Filing Icon  
6/14/2024Lori A. WoodsDirectorBuy4,587$10.90$49,998.30159,985View SEC Filing Icon  
6/13/2024Johan M SpoorCEOBuy10,000$11.70$117,000.0013,757View SEC Filing Icon  
6/3/2024Lori A. WoodsDirectorBuy3,424$14.60$49,990.40155,398View SEC Filing Icon  
5/31/2024Jonathan Robert HuntCFOBuy2,500$14.00$35,000.0034,171View SEC Filing Icon  
5/31/2024Robert F. Williamson, IIIDirectorBuy5,500$13.80$75,900.0042,379View SEC Filing Icon  
5/29/2024Robert F. Williamson, IIIDirectorBuy3,003$13.30$39,939.9036,879View SEC Filing Icon  
3/6/2024Lantheus Alpha Therapy, LlcMajor ShareholderBuy6,043,103$9.50$57,409,478.5011,677,339View SEC Filing Icon  
1/29/2024Robert F. Williamson, IIIDirectorBuy2,526$6.40$16,166.4021,155View SEC Filing Icon  
1/25/2024Robert F. Williamson, IIIDirectorBuy2,213$4.90$10,843.707,567View SEC Filing Icon  
1/24/2024Markus PuhlmannInsiderBuy28,000$5.00$140,000.00137,542View SEC Filing Icon  
12/21/2023Robert F. Williamson, IIIDirectorBuy366$3.30$1,207.80366View SEC Filing Icon  
12/18/2023Jonathan Robert HuntCFOBuy12,500$2.60$32,500.0031,671View SEC Filing Icon  
12/18/2023Markus PuhlmannInsiderBuy6,041$2.60$15,706.6069,542View SEC Filing Icon  
12/18/2023Robert F. Williamson, IIIDirectorBuy1,000$2.60$2,600.001,000View SEC Filing Icon  
12/15/2023Markus PuhlmannInsiderBuy13,500$2.70$36,450.0063,500View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Perspective Therapeutics (NYSEAMERICAN:CATX)

54.66% of Perspective Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CATX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Perspective Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/3/2026Caitong International Asset Management Co. Ltd30,627$84K0.0%N/A0.041%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd82,476$0.23M0.0%+36.5%0.111%Search for SEC Filing on Google Icon
2/18/2026nVerses Capital LLC11,420$31K0.1%N/A0.015%Search for SEC Filing on Google Icon
2/18/2026Sphera Funds Management LTD.349,973$0.96M0.2%-31.4%0.471%Search for SEC Filing on Google Icon
2/18/2026Opaleye Management Inc.1,184,500$3.26M0.4%N/A1.593%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC1,406,374$3.87M0.0%-45.1%1.892%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP12,562$35K0.0%N/A0.017%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC95,193$0.26M0.0%N/A0.128%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC62,370$0.17M0.0%N/A0.084%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.80,193$0.22M0.0%+76.8%0.108%Search for SEC Filing on Google Icon
2/16/2026Avidity Partners Management LP3,210,733$8.83M2.5%+7.2%4.319%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC92,791$0.26M0.0%+10.7%0.125%Search for SEC Filing on Google Icon
2/16/2026Aigen Investment Management LP10,173$28K0.0%N/A0.014%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP406,732$1.12M0.0%N/A0.547%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 19,031$52K0.0%-10.6%0.026%Search for SEC Filing on Google Icon
2/13/2026Walleye Capital LLC328,667$0.90M0.0%-39.8%0.442%Search for SEC Filing on Google Icon
2/13/2026State Street Corp1,141,247$3.14M0.0%+3.3%1.535%Search for SEC Filing on Google Icon
2/13/2026Vontobel Holding Ltd.25,000$69K0.0%+25.0%0.034%Search for SEC Filing on Google Icon
2/13/2026Caitong International Asset Management Co. Ltd15,208$42K0.1%N/A0.020%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN66,820$0.18M0.0%+46.2%0.090%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC16,717$46K0.0%-43.4%0.022%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC352,493$0.97M0.0%N/A0.474%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP91,557$0.25M0.0%N/A0.123%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.213,759$0.59M0.0%+7.9%0.288%Search for SEC Filing on Google Icon
2/12/2026Patient Square Capital LP1,132,815$3.12M0.7%+224.3%1.524%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC1,274,007$3.50M0.0%-2.6%1.714%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG54,245$0.15M0.0%+6.1%0.073%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.159,837$0.44M0.0%-19.2%0.215%Search for SEC Filing on Google Icon
2/10/2026AXQ Capital LP12,749$35K0.0%+24.2%0.017%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC25,702$71K0.0%-14.1%0.035%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC1,414,522$3.89M0.0%-1.3%1.903%Search for SEC Filing on Google Icon
2/5/2026Hills Bank & Trust Co938,200$2.58M0.2%-4.2%1.262%Search for SEC Filing on Google Icon
1/30/2026R Squared Ltd15,991$44K0.0%N/A0.022%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG926,331$2.55M0.0%+44.5%1.246%Search for SEC Filing on Google Icon
1/21/2026Trueblood Wealth Management LLC119,061$0.33M0.1%+72.4%0.160%Search for SEC Filing on Google Icon
1/16/2026Taylor & Morgan Wealth Management LLC97,000$0.27M0.1%+6.6%0.130%Search for SEC Filing on Google Icon
1/14/2026Auctus Advisors LLC31,673$87K0.1%N/A0.043%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.436,357$1.50M0.0%-41.7%0.587%Search for SEC Filing on Google Icon
11/17/2025Susquehanna International Group LLP51,304$0.18M0.0%-55.9%0.069%Search for SEC Filing on Google Icon
11/17/2025Sherbrooke Park Advisers LLC32,425$0.11M0.1%N/A0.044%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd68,959$0.24M0.0%-27.2%0.093%Search for SEC Filing on Google Icon
11/17/2025Mariner LLC86,116$0.30M0.0%+33.6%0.116%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV29,275$100K0.0%+81.8%0.039%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC2,561,112$8.79M0.0%-1.3%3.449%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.27,986$96K0.0%-14.2%0.038%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE785,823$2.70M0.0%+139.9%1.058%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP519,668$1.78M0.0%-13.6%0.700%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC95,800$0.33M0.0%-13.5%0.129%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG641,143$2.20M0.0%+72.0%0.863%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets103,736$0.36M0.0%-57.2%0.140%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.8,449$29K0.0%+184.1%0.011%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC29,924$0.10M0.0%-23.3%0.040%Search for SEC Filing on Google Icon
11/10/2025AXQ Capital LP10,268$35K0.0%-49.9%0.014%Search for SEC Filing on Google Icon
11/10/2025Patient Square Capital LP349,323$1.20M0.3%N/A0.470%Search for SEC Filing on Google Icon
11/10/2025Siligmueller & Norvid Wealth Advisors LLC164,711$0.57M0.3%N/A0.222%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.3,437,865$11.79M0.0%+5.0%4.629%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.436,357$1.50M0.0%-41.7%0.588%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC13,538$46K0.0%N/A0.018%Search for SEC Filing on Google Icon
10/15/2025Taylor & Morgan Wealth Management LLC91,000$0.31M0.2%-3.2%0.123%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC10,675$37K0.0%-35.5%0.014%Search for SEC Filing on Google Icon
8/15/2025Engineers Gate Manager LP28,708$99K0.0%-75.9%0.039%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets242,610$0.84M0.0%+227.1%0.327%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC110,800$0.38M0.0%-11.4%0.149%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE327,500$1.13M0.0%+8.5%0.441%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd94,693$0.33M0.0%-22.4%0.128%Search for SEC Filing on Google Icon
8/14/2025Federated Hermes Inc.195,080$0.67M0.0%+44.4%0.263%Search for SEC Filing on Google Icon
8/13/2025Affinity Asset Advisors LLC1,050,000$3.61M0.5%-52.8%1.415%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP520,707$1.79M0.0%-54.1%0.701%Search for SEC Filing on Google Icon
8/13/2025Walleye Capital LLC187,403$0.65M0.0%+375.8%0.252%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers83,250$0.29M0.0%-15.2%0.112%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.748,067$2.57M0.0%+118.4%1.008%Search for SEC Filing on Google Icon
8/8/2025Citizens Financial Group Inc. RI53,100$0.18M0.0%-46.9%0.072%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC1,382,814$4.76M0.0%+15.8%1.863%Search for SEC Filing on Google Icon
8/7/2025Los Angeles Capital Management LLC17,595$61K0.0%N/A0.024%Search for SEC Filing on Google Icon
8/5/2025Hills Bank & Trust Co984,200$3.39M0.2%-3.9%1.326%Search for SEC Filing on Google Icon
7/31/2025Ground Swell Capital LLC16,373$56K0.1%N/A0.022%Search for SEC Filing on Google Icon
7/29/2025Nicholson Wealth Management Group LLC1,614,283$5.55M3.4%+0.3%2.175%Search for SEC Filing on Google Icon
7/23/2025Trueblood Wealth Management LLC69,061$0.24M0.1%+210.6%0.093%Search for SEC Filing on Google Icon
7/15/2025Wealth Effects LLC24,000$83K0.0%-38.5%0.032%Search for SEC Filing on Google Icon
7/7/2025Taylor & Morgan Wealth Management LLC94,000$0.32M0.2%+4.4%0.127%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.302,819$0.65M0.0%-66.5%0.408%Search for SEC Filing on Google Icon
5/16/2025Octagon Capital Advisors LP2,250,000$4.79M0.5%-2.4%3.038%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.302,819$0.65M0.0%-66.5%0.409%Search for SEC Filing on Google Icon
5/15/2025Cubist Systematic Strategies LLC51,480$0.11M0.0%-80.3%0.070%Search for SEC Filing on Google Icon
5/14/2025Affinity Asset Advisors LLC2,224,196$4.74M0.5%+71.1%3.004%Search for SEC Filing on Google Icon
5/14/2025MetLife Investment Management LLC31,310$67K0.0%+40.9%0.042%Search for SEC Filing on Google Icon
5/14/2025Walleye Capital LLC39,390$84K0.0%-91.7%0.053%Search for SEC Filing on Google Icon
5/13/2025HighTower Advisors LLC201,586$0.43M0.0%+13.2%0.272%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC1,242,542$2.65M0.0%N/A1.678%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.434,085$0.93M0.0%+6.7%0.586%Search for SEC Filing on Google Icon
5/9/2025Citizens Financial Group Inc. RI100,000$0.21M0.0%+100.0%0.135%Search for SEC Filing on Google Icon
5/8/2025Federated Hermes Inc.135,061$0.29M0.0%N/A0.182%Search for SEC Filing on Google Icon
5/5/2025AMG National Trust Bank23,423$50K0.0%-21.9%0.032%Search for SEC Filing on Google Icon
4/29/2025Bank of New York Mellon Corp159,366$0.34M0.0%+11.1%0.215%Search for SEC Filing on Google Icon
4/8/2025Taylor & Morgan Wealth Management LLC90,000$0.19M0.1%+60.7%0.122%Search for SEC Filing on Google Icon
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC70,150$0.22M0.0%+19.6%0.104%Search for SEC Filing on Google Icon
2/17/2025Velan Capital Investment Management LP500,000$1.60M1.4%N/A0.740%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC196,208$0.63M0.0%N/A0.290%Search for SEC Filing on Google Icon
2/17/2025Wexford Capital LP20,000$64K0.0%N/A0.030%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Advisers LP151,610$0.48M0.0%N/A0.224%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Perspective Therapeutics logo
Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company discovers, designs, and develop its initial programs candidates consists of VMT-a-NET, that is currently in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta-emitting therapy; and VMT01, which is currently in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma. Perspective Therapeutics, Inc. has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Read More on Perspective Therapeutics

Today's Range

Now: $4.45
Low: $4.40
High: $4.78

50 Day Range

MA: $4.37
Low: $2.33
High: $5.65

52 Week Range

Now: $4.45
Low: $1.60
High: $6.16

Volume

7,431,120 shs

Average Volume

1,627,624 shs

Market Capitalization

$330.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7

Who are the company insiders with the largest holdings of Perspective Therapeutics?

Perspective Therapeutics' top insider shareholders include:
  1. Robert F Williamson III (Director)
  2. Lori A Woods (Director)
  3. Johan M Spoor (CEO)
  4. Jonathan Robert Hunt (CAO)
  5. Jonathan Robert Hunt (CFO)
  6. Juan Graham (CFO)
  7. Heidi Henson (Director)
Learn More about top insider investors at Perspective Therapeutics.

Who are the major institutional investors of Perspective Therapeutics?

Perspective Therapeutics' top institutional investors include:
  1. Avidity Partners Management LP — 4.32%
  2. Geode Capital Management LLC — 1.90%
  3. Millennium Management LLC — 1.89%
  4. Nuveen LLC — 1.71%
  5. Opaleye Management Inc. — 1.59%
  6. State Street Corp — 1.54%
Learn More about top institutional investors of Perspective Therapeutics stock.

Which major investors are selling Perspective Therapeutics stock?

Within the previous quarter, CATX stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Walleye Capital LLC
  3. Sphera Funds Management LTD.
  4. Hills Bank & Trust Co
  5. Goldman Sachs Group Inc.
  6. Nuveen LLC
  7. Geode Capital Management LLC
  8. MetLife Investment Management LLC

Which major investors are buying Perspective Therapeutics stock?

Within the previous quarter, CATX stock was acquired by institutional investors including:
  1. Opaleye Management Inc.
  2. Patient Square Capital LP
  3. Marshall Wace LLP
  4. Renaissance Technologies LLC
  5. UBS Group AG
  6. Avidity Partners Management LP
  7. ADAR1 Capital Management LLC
  8. Dimensional Fund Advisors LP
Within the previous year, these company insiders have bought Perspective Therapeutics stock:
  1. Robert F Williamson III (Director)
  2. Lori A Woods (Director)
  3. Johan M Spoor (CEO)
  4. Jonathan Robert Hunt (CAO)
  5. Jonathan Robert Hunt (CFO)
  6. Juan Graham (CFO)
  7. Heidi Henson (Director)
Learn More investors buying Perspective Therapeutics stock.